Login to Your Account



Regulatory NEWS

Taking stock of the lessons being learned from the ongoing Ebola epidemic in West Africa and other health care emergencies, members of the Senate Health, Education, Labor and Pensions Committee got an earful Thursday.

PRICE, ACCESS AT ISSUE

NEW DELHI – In a test of India's law requiring sponsors of patented drugs to manufacture sufficient quantities in country, Cipla Ltd.'s challenge of Novartis AG's Indian patent for its COPD drug Onbrez is raising questions about the correct way to contest a pharma patent.

In a case that could limit the Federal Trade Commission's (FTC) reach in challenging pay-for-delay settlements, a federal appeals court Friday ruled that a lower court was correct in denying the commission access to documents about a co-promotion deal Boehringer Ingelheim Pharmaceuticals Inc. reached with Barr Laboratories Inc. as part of a patent settlement.

More Regulatory Headlines

Cast Your Vote

Has biotech’s bubble burst?: